Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
ViroMissile, Inc.
Eisai Inc.
SEED Therapeutics, Inc.
Seattle Children's Hospital
St. Jude Children's Research Hospital
MacroGenics
City of Hope Medical Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Seattle Children's Hospital
Baylor College of Medicine
HiFiBiO Therapeutics
GONGCHU Biotechnology Co., Ltd
Jonsson Comprehensive Cancer Center
Children's National Research Institute
TopAlliance Biosciences
National Cancer Institute (NCI)
Xencor, Inc.
National Cancer Institute (NCI)
BioEclipse Therapeutics
Children's National Research Institute
Tempest Therapeutics
Eli Lilly and Company
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
National Cancer Institute (NCI)
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NYU Langone Health
Case Comprehensive Cancer Center